Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis

Lancet

Volumn 355, Issue 9210, 2000, Pages 1131-1137

  Babiker, A ^a   Darby, S ^a   De Angelis, D ^a   Ewart, D ^a   Porter, K ^a   Beral, V ^a   Darbyshire, J ^a   Day, N ^a   Gill, N ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGE; AGED; ARTICLE; AUSTRALIA; CAUSE OF DEATH; CHILD; DATA ANALYSIS; EUROPE; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCUBATION TIME; INTERNATIONAL COOPERATION; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MORTALITY; NONHUMAN; NORTH AMERICA; PRIORITY JOURNAL; SEROCONVERSION; SURVIVAL TIME;

EID: 0034176789     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)02061-4     Document Type: Article

References (26)

1. Phillips A.N., Lee C.A., Elford J.et al. More rapid progression to AIDS in older HIV-infected people: the role of CD4+ T-cell counts. J Acquir Immune Defic Syndr. 4:1991;970-975.
2. Mariotto A.B., Mariotti S., Pezzotti P., Rezza G., Verdecchia A. Estimation of the acquired immunodeficiency syndrome incubation period in intravenous drug users. a comparison with male homosexuals Am J Epidemiol. 135:1992;428-437.
3. Rosenberg P.S., Goedert J.J., Biggar R.J. Effect of age at seroconversion on the natural AIDS incubation distribution. AIDS. 8:1994;803-810.
4. Touloumi G., Hatzakis A., Rosenberg P.S., O'Brien T.R., Goedert J.J. Effects of age at seroconversion and baseline HIV RNA level on the loss of CD4+ cells among persons with hemophilia. AIDS. 12:1998;1691-1697.
5. The AIDS incubation period in the UK estimated from a national register of HIV seroconverters. AIDS. 12:1998;659-667.
6. Altisent C., Montoro J.B., Ruiz I., Lorenzo J.I. Long-term survivors and progression of human immunodeficiency virus infection. N Engl J Med. 334:1996;1065-1066.
7. Operskalski E.A., Stram D.O., Lee H.et al. Human immunodeficiency virus type 1 infection: relationship of risk group and age to rate of progression to AIDS. J Infect Dis. 172:1995;648-655.
8. Darby S.C., Ewart D.W., Giangrande P.L., Spooner R.J., Rizza C.R. Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population. Lancet. 347:1996;1573-1579.
9. Kopec Schrader E., Tindall B., Learmont J., Wylie B., Kaldor J.M. Development of AIDS in people with transfusion-acquired HIV infection. AIDS. 7:1993;1009-1013.
10. Carré N., Meyer L., Boufassa F.et al. High risk of HIV disease progression after infection through a sexual partner with AIDS. AIDS. 10:1996;77-80.
11. Goedert J.J., Kessler C.M., Aledort L.M.et al. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med. 321:1989;1141-1148.
12. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts, part 1. AIDS. 8:1994;911-921.
13. Carré N., Deveau C., Belanger F.et al. Effect of age and exposure group on the onset of AIDS in heterosexual and homosexual HIV-infected patients. AIDS. 8:1994;797-802.
14. Pehrson P., Lindbäck S., Lidman C., Gaines H., Giesecke J. Longer survival after HIV infection for injecting drug users than for homosexual men: implications for immunology. AIDS. 11:1997;1007-1012.
15. New case definition. Lancet. 341:1993;441.
16. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR. 41( ):1992;1-19.
17. Crowe S.M., Carlin J.B., Stewart K.I., Luca C.R., Hoy J.F. Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons. J Acquir Immune Defic Syndr. 4:1991;770-776.
18. Mortality statistics: review of the Registrar General on deaths in England and Wales, 1990. Series DH1 no 24. 1990;HM Stationery Office, London.
19. Brettle R.P., McNeil A.J., Burns S.et al. Progression of HIV: follow-up of Edinburgh injecting drug users with narrow seroconversion intervals in 1983-1985. AIDS. 10:1996;419-430.
20. Hessol N.A., Koblin B.A., van Griensven G.J.P.et al. Progression of human immunodeficiency virus type 1 (HIV-1) infection among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1991. Am J Epidemiol. 139:1994;1077-1087.
21. Veugelers P.J., Page K.J., Tindall B.et al. Determinants of HIV disease progression among homosexual men registered in the Tricontinental seroconverter study. Am J Epidemiol. 140:1994;747-758.
22. von Overbeck J., Egger M., Davey Smith G.et al. Survival in HIV infection, do sex and category of transmission matter? AIDS. 8:1994;1307-1313.
23. Longini I.M., Clark W.S., Gardner L.I., Brundage J.F. The dynamics of CD+4 T-lymphocyte decline in HIV-infected individuals. a Markov modelling approach J Acquir Immune Defic Syndr. 4:1991;1141-1147.
24. Eyster M.E., Diamondstone L.S., Lien J.M., Ehmann W.C., Quan S., Goedert J.J. Natural history of hepatitis C virus infection in multitransfused hemophiliacs. effect of coinfection with human immunodeficiency virus J Acquir Immune Defic Syndr. 6:1993;602-610.
25. Darby S.C., Ewart D.W., Giangrande P.L.F.et al. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. Lancet. 350:1997;1425-1431.
26. Poynard T., Bedossa P., Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet. 349:1997;825-832.